NM_000040.3:c.-14+121G>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000040.3(APOC3):​c.-14+121G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.267 in 185,628 control chromosomes in the GnomAD database, including 7,787 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6884 hom., cov: 32)
Exomes 𝑓: 0.21 ( 903 hom. )

Consequence

APOC3
NM_000040.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.326

Publications

8 publications found
Variant links:
Genes affected
APOC3 (HGNC:610): (apolipoprotein C3) This gene encodes a protein component of triglyceride (TG)-rich lipoproteins (TRLs) including very low density lipoproteins (VLDL), high density lipoproteins (HDL) and chylomicrons. The encoded protein plays a role in role in the metabolism of these TRLs through multiple modes. This protein has been shown to promote the secretion of VLDL1, inhibit lipoprotein lipase enzyme activity, and delay catabolism of TRL remnants. Mutations in this gene are associated with low plasma triglyceride levels and reduced risk of ischemic cardiovascular disease, and hyperalphalipoproteinemia, which is characterized by elevated levels of high density lipoprotein (HDL) and HDL cholesterol in human patients. This gene and other related genes comprise an apolipoprotein gene cluster on chromosome 11. [provided by RefSeq, Sep 2017]
APOC3 Gene-Disease associations (from GenCC):
  • cholesterol-ester transfer protein deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOC3NM_000040.3 linkc.-14+121G>C intron_variant Intron 1 of 3 ENST00000227667.8 NP_000031.1 P02656A3KPE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOC3ENST00000227667.8 linkc.-14+121G>C intron_variant Intron 1 of 3 1 NM_000040.3 ENSP00000227667.2 P02656
APOC3ENST00000375345.3 linkc.-37+121G>C intron_variant Intron 1 of 3 5 ENSP00000364494.1 B0YIW2
APOC3ENST00000433777.5 linkc.-14+175G>C intron_variant Intron 1 of 2 5 ENSP00000410614.1 C9J2Q0
APOC3ENST00000470144.1 linkn.19+121G>C intron_variant Intron 1 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42591
AN:
151790
Hom.:
6886
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.439
Gnomad AMI
AF:
0.265
Gnomad AMR
AF:
0.195
Gnomad ASJ
AF:
0.264
Gnomad EAS
AF:
0.0604
Gnomad SAS
AF:
0.154
Gnomad FIN
AF:
0.160
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.266
GnomAD4 exome
AF:
0.207
AC:
6975
AN:
33720
Hom.:
903
AF XY:
0.205
AC XY:
3546
AN XY:
17286
show subpopulations
African (AFR)
AF:
0.393
AC:
402
AN:
1022
American (AMR)
AF:
0.161
AC:
499
AN:
3098
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
208
AN:
868
East Asian (EAS)
AF:
0.0497
AC:
105
AN:
2112
South Asian (SAS)
AF:
0.163
AC:
422
AN:
2586
European-Finnish (FIN)
AF:
0.150
AC:
158
AN:
1054
Middle Eastern (MID)
AF:
0.258
AC:
34
AN:
132
European-Non Finnish (NFE)
AF:
0.226
AC:
4738
AN:
21010
Other (OTH)
AF:
0.223
AC:
409
AN:
1838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
248
495
743
990
1238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.280
AC:
42610
AN:
151908
Hom.:
6884
Cov.:
32
AF XY:
0.274
AC XY:
20319
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.438
AC:
18151
AN:
41394
American (AMR)
AF:
0.195
AC:
2976
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
916
AN:
3464
East Asian (EAS)
AF:
0.0603
AC:
309
AN:
5124
South Asian (SAS)
AF:
0.154
AC:
742
AN:
4820
European-Finnish (FIN)
AF:
0.160
AC:
1692
AN:
10590
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.249
AC:
16945
AN:
67928
Other (OTH)
AF:
0.262
AC:
552
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1494
2988
4482
5976
7470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.270
Hom.:
721
Bravo
AF:
0.290
Asia WGS
AF:
0.120
AC:
415
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.3
DANN
Benign
0.44
PhyloP100
0.33
PromoterAI
-0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs618354; hg19: chr11-116700777; API